Paroxysmal cough is an increasingly common condition that has been gaining more attention in the medical community. It is characterized by sudden, repeated episodes of coughing that can last for minutes or even hours. The condition can be debilitating and significantly reduce quality of life. Despite its prevalence, the cause of paroxysmal cough is still largely unknown. This article explores the current understanding of the condition, its diagnosis, and potential treatments.
Paroxysmal cough is a condition characterized by sudden, repeated episodes of coughing. The coughing fits can last for minutes or even hours and can be very severe. During these episodes, the person may experience shortness of breath, chest pain, or even vomiting. The coughing fits can occur at any time, day or night, and can be triggered by a variety of factors such as exercise, cold air, or even talking.
Due to the sudden onset of the coughing fits, diagnosis of paroxysmal cough can be difficult. Doctors typically start by ruling out other conditions that may be causing the coughing, such as asthma, allergies, or GERD. If these conditions are ruled out, then a diagnosis of paroxysmal cough is made. In order to confirm the diagnosis, doctors may use a variety of tests, such as chest X-rays, pulmonary function tests, or even a bronchoscopy. These tests are used to rule out other conditions and to look for any underlying causes of the coughing.
Unfortunately, there is no cure for paroxysmal cough. Treatment typically focuses on managing the symptoms and reducing the frequency and severity of the coughing fits. This can include avoiding triggers, such as cold air or exercise, and taking medications to reduce the inflammation in the airways. In some cases, doctors may recommend more aggressive treatments, such as steroids or immunotherapy. These treatments are typically used in cases where the coughing is severe and other treatments have not been successful.
Paroxysmal cough is an increasingly common condition that can be debilitating and significantly reduce quality of life. Despite its prevalence, the cause of paroxysmal cough is still largely unknown. Doctors typically diagnose the condition by ruling out other conditions and using tests to look for underlying causes. Treatment typically focuses on managing the symptoms and reducing the frequency and severity of the coughing fits. In some cases, more aggressive treatments, such as steroids or immunotherapy, may be necessary. With greater understanding of the condition, doctors will be better equipped to diagnose and treat paroxysmal cough, leading to improved respiratory health for those affected.
1.
FDA OKs Subcutaneous Daratumumab Plus VRd for Myeloma
2.
The Early Progression of Prostate Cancer Is Not Stopped by Metformin.
3.
Hydroxyurea Shows Some Benefits in Milder Sickle Cell Disease
4.
Study confirms safety and efficacy of higher-dose-per-day radiation for early-stage prostate cancer
5.
Tipiracil hydrochloride and trifluridine tablets are approved by the USFDA for Natco Pharma.
1.
Understanding Adenomyosis: The Role of Ultrasound in Diagnosis Introduction
2.
Undersanding Alemtuzumab: What You Need To Know About This Multiple Sclerosis Medication
3.
Understanding Iron Saturation Levels in Your Blood
4.
Beyond the Tumor: Emerging Frontiers in Cancer Systems Biology
5.
Subarachnoid Hemorrhage: Emerging Insights into Pathophysiology and Future Management
1.
International Lung Cancer Congress®
2.
Genito-Urinary Oncology Summit 2026
3.
Future NRG Oncology Meeting
4.
ISMB 2026 (Intelligent Systems for Molecular Biology)
5.
Annual International Congress on the Future of Breast Cancer East
1.
Lorlatinib in the Management of 1st line ALK+ mNSCLC (CROWN TRIAL Update) - Conclusion
2.
Management of 1st line ALK+ mNSCLC (CROWN TRIAL Update) - Part IV
3.
CDK4/6 Inhibitors in Extending Overall Survival in HR+/HER2- aBC Patients in Clinical Trial and Real World
4.
Should We Use DARA Up Front As First-Line Therapy in MM? - Part II
5.
A Comprehensive Guide to First Line Management of ALK Positive Lung Cancer - Part III
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation